Transcription factor Ets-1 is essential for mesangial matrix remodeling

Kidney International

Volumn 70, Issue 2, 2006, Pages 298-305

  Mizui, M ^a   Isaka, Y ^a   Takabatake, Y ^a   Sato, Y ^b   Kawachi, H ^c   Shimizu, F ^c   Takahara, S ^a   Ito, T ^a   Imai, E ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Gene therapy; Mesangial cells; TGF

Indexed keywords

COLLAGEN GEL; COLLAGEN TYPE 1; DNA; FIBRONECTIN; GELATINASE B; INTERSTITIAL COLLAGENASE; MESSENGER RNA; STROMELYSIN; TRANSCRIPTION FACTOR ETS 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA BINDING; ETS 1 GENE; EXTRACELLULAR MATRIX; GENE; GENETIC TRANSFECTION; GLOMERULOPATHY; KIDNEY; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT;

ANIMALS; CELLS, CULTURED; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GLOMERULONEPHRITIS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MESANGIAL CELLS; PROTO-ONCOGENE PROTEIN C-ETS-1; RATS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 33746126114     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001541     Document Type: Article

References (43)

1. Ishimura E, Sterzel RB, Budde K et al. Formation of extracellular matrix by cultured rat mesangial cells. Am J Pathol 1989; 134: 843-855.
2. Natori Y, O'Meara YM, Manning EC et al. Production and polarized secretion of basement membrane components by glomerular epithelial cells. Am J Physiol 1992; 262: F131-F137.
3. Norman JT, Fine LG. Progressive renal disease: fibroblasts, extracellular matrix, and integrins. Exp Nephrol 1999; 7: 167-177.
4. Yoshioka K, Tohda M, Takemura T et al. Distribution of type I collagen in human kidney diseases in comparison with type III collagen. J Pathol 1990; 162: 141-148.
5. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301.
6. Kola I, Brookes S, Green AR et al. The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA 1993; 90: 7588-7592.
7. Oda N, Abe M, Sato Y. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 1999; 178: 121-132.
8. Reisdorff J, En-Nia A, Stefanidis I et al. Transcription factor Ets-1 regulates gelatinase a gene expression in mesangial cells. J Am Soc Nephrol 2002; 13: 1568-1578.
9. Vandenbunder B, Pardanaud L, Jaffredo T et al. Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. Development 1989; 107: 265-274.
10. Wasylyk B, Wasylyk C, Flores P et al. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 1990; 346: 191-193.
11. Gum R, Lengyel E, Juarez J et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 1996; 271: 10672-10680.
12. Gutman A, Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 1990; 9: 2241-2246.
13. Iwasaka C, Tanaka K, Abe M et al. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 1996; 169: 522-531.
14. Logan SK, Garabedian MJ, Campbell CE et al. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J Biol Chem 1996; 271: 774-782.
15. Nerlov C, De Cesare D, Pergola F et al. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J 1992; 11: 4573-4582.
16. Wasylyk C, Gutman A, Nicholson R et al. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 1991; 10: 1127-1134.
17. Sato Y. Transcription factor ETS-1 as a molecular target for angiogenesis inhibition. Hum Cell 1998; 11: 207-214.
18. Cederberg A, Hulander M, Carlsson P et al. The kidney-expressed winged helix transcription factor FREAC-4 is regulated by Ets-1. A possible role in kidney development. J Biol Chem 1999; 274: 165-169.
19. Naito T, Razzaque MS, Nazneen A et al. Renal expression of the Ets-1 proto-oncogene during progression of rat crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11: 2243-2255.
20. Raffetseder U, Wernert N, Ostendorf T et al. Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis. Kidney Int 2004; 66: 622-632.
21. Kagami S, Kondo S, Loster K et al. Alpha1beta1 integrin-mediated collagen matrix remodeling by rat mesangial cells is differentially regulated by transforming growth factor-beta and platelet-derived growth factor-BB. J Am Soc Nephrol 1999; 10: 779-789.
22. Tsujie M, Isaka Y, Nakamura H et al. Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 2001; 12: 949-954.
23. Border W, Noble N. Transforming growth factor in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
24. Douthwaite JA, Johnson TS, Haylor JL et al. Effects of transforming growth factor-beta1 on renal extracellular matrix components and their regulating proteins. J Am Soc Nephrol 1999; 10: 2109-2119.
25. Basuyaux JP, Ferreira E, Stehelin D et al. The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner. J Biol Chem 1997; 272: 26188-26195.
26. Czuwara-Ladykowska J, Sementchenko VI, Watson DK et al. Ets1 is an effector of the transforming growth factor beta (TGF-beta) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J Biol Chem 2002; 277: 20399-20408.
27. Racine-Samson L, Rockey DC, Bissell DM. The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. J Biol Chem 1997; 272: 30911-30917.
28. Nunes I, Gleizes PE, Metz CN et al. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 1997; 136: 1151-1163.
29. Johnson TS, Skill NJ, El Nahas AM et al. Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol 1999; 10: 2146-2157.
30. Tomita N, Morishita R, Taniyama Y et al. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 2003; 107: 1411-1417.
31. Chernavvsky DR, Fernandez LG, Barton K et al. Expression and function of the ETS-1 gene in the developing kidney [Abstract]. J Am Soc Nephrol 1998; 9: 360A.
32. Okuda S, Languino LR, Ruoslahti E et al. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990; 86: 453-462.
33. Tomooka S, Border WA, Marshall BC et al. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 1992; 42: 1462-1469.
34. Kagami S, Border WA, Ruoslahti E et al. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest 1993; 69: 68-76.
35. Tanaka K, Oda N, Iwasaka C et al. Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J Cell Physiol 1998; 176: 235-244.
36. Sato Y, Kanno S, Oda N et al. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann N Y Acad Sci 2000; 902: 201-205; discussion 205-207.
37. Hugo C, Shankland SJ, Bowen-Pope DF et al. Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. J Clin Invest 1997; 100: 786-794.
38. Masuda Y, Shimizu A, Mori T et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001; 159: 599-608.
39. Mizuno S, Kurosawa T, Matsumoto K et al. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998; 101: 1827-1834.
40. Teruyama K, Abe M, Nakano T et al. Role of transcription factor Ets-1 in the apoptosis of human vascular endothelial cells. J Cell Physiol 2001; 188: 243-252.
41. Isaka Y, Nakamura H, Mizui M et al. DNAzyme for TGF-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 2004; 66: 586-590.
42. Nakamura H, Isaka Y, Tsujie M et al. Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Gene Therapy 2002; 9: 495-502.
43. Kawachi H, Orikasa M, Matsui K et al. Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen. Clin Exp Immunol 1992; 88: 399-404.